139 related articles for article (PubMed ID: 38642508)
41. Mixed connective tissue disease.
Venables PJ
Lupus; 2006; 15(3):132-7. PubMed ID: 16634365
[TBL] [Abstract][Full Text] [Related]
42. Autoantibodies to small nuclear ribonucleoproteins. A strong association between anti-SS-B(La), HLA-B8, and Sjögren's syndrome.
Whittingham S; Mackay IR; Tait BD
Aust N Z J Med; 1983 Dec; 13(6):565-70. PubMed ID: 6609699
[TBL] [Abstract][Full Text] [Related]
43. More evidence of distinctive features of mixed connective tissue disease.
Hämeenkorpi R; Ruuska P; Forsberg S; Tiilikainen R; Mäkitalo R; Hakala M
Scand J Rheumatol; 1993; 22(2):63-8. PubMed ID: 8480140
[TBL] [Abstract][Full Text] [Related]
44. Significance of anti-ENA, Sm and RNP antibodies in patients with antinuclear antibodies.
Levo Y; Lotan C
Isr J Med Sci; 1982 Feb; 18(2):287-9. PubMed ID: 6978327
[No Abstract] [Full Text] [Related]
45. Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers.
Cavazzana I; Vojinovic T; Airo' P; Fredi M; Ceribelli A; Pedretti E; Lazzaroni MG; Garrafa E; Franceschini F
Clin Rev Allergy Immunol; 2023 Jun; 64(3):412-430. PubMed ID: 35716254
[TBL] [Abstract][Full Text] [Related]
46. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
Hamaguchi Y
J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
[TBL] [Abstract][Full Text] [Related]
47. Basophils and IgE contribute to mixed connective tissue disease development.
Lamri Y; Vibhushan S; Pacreau E; Boedec E; Saidoune F; Mailleux A; Crestani B; Blank U; Benhamou M; Papo T; Daugas E; Sacré K; Charles N
J Allergy Clin Immunol; 2021 Apr; 147(4):1478-1489.e11. PubMed ID: 33338538
[TBL] [Abstract][Full Text] [Related]
48. Nailfold capillaroscopy abnormalities and pulmonary hypertension in mixed connective tissue disease and systemic sclerosis patients.
Munteanu A; Kundnani NR; Caraba A
Eur Rev Med Pharmacol Sci; 2024 Feb; 28(4):1314-1326. PubMed ID: 38436165
[TBL] [Abstract][Full Text] [Related]
49. Anti-SMN autoantibodies in mixed connective tissue disease are associated with a severe systemic sclerosis phenotype.
El Kamouni H; S Jalaledin D; Albert A; Hoa S; Vo C; Bourré-Tessier J; Rich É; Goulet JR; Koenig M; Pérez G; Choi MY; Troyanov Y; Satoh M; Fritzler MJ; Senécal JL; Landon-Cardinal O
RMD Open; 2023 Oct; 9(4):. PubMed ID: 37797966
[TBL] [Abstract][Full Text] [Related]
50. Frequent coexistence of anti-topoisomerase I and anti-U1RNP autoantibodies in African American patients associated with mild skin involvement: a retrospective clinical study.
Satoh M; Krzyszczak ME; Li Y; Ceribelli A; Ross SJ; Chan EK; Segal MS; Bubb MR; Sobel ES; Reeves WH
Arthritis Res Ther; 2011 May; 13(3):R73. PubMed ID: 21569292
[TBL] [Abstract][Full Text] [Related]
51. Nailfold capillaroscopy and autoimmune connective tissue diseases in patients from a Portuguese nailfold capillaroscopy clinic.
Bernardino V; Rodrigues A; Lladó A; Panarra A
Rheumatol Int; 2020 Feb; 40(2):295-301. PubMed ID: 31451935
[TBL] [Abstract][Full Text] [Related]
52. Scleroderma overlap syndromes.
Jablonska S; Blaszczyk M
Adv Exp Med Biol; 1999; 455():85-92. PubMed ID: 10599327
[TBL] [Abstract][Full Text] [Related]
53. Anti-survival motor neuron complex antibodies as a novel biomarker for pulmonary arterial hypertension and interstitial lung disease in mixed connective tissue disease.
Todoroki Y; Satoh M; Kubo S; Kosaka S; Fukuyo S; Nakatsuka K; Saito K; Tanaka S; Nakayamada S; Tanaka Y
Rheumatology (Oxford); 2024 Apr; 63(4):1068-1075. PubMed ID: 37421400
[TBL] [Abstract][Full Text] [Related]
54. 'Autoantibody dominance' pattern following idiotypic manipulation of naive mice by immunization with anti-U1RNP antibodies.
George J; Gilburd B; Levy Y; Afec A; Damianovich M; Ghirardello A; Doria A; Todesco S; Shoenfeld Y
Pathobiology; 1997; 65(4):204-9. PubMed ID: 9396044
[TBL] [Abstract][Full Text] [Related]
55. Distinct phenotypes in mixed connective tissue disease: subgroups and survival.
Szodoray P; Hajas A; Kardos L; Dezso B; Soos G; Zold E; Vegh J; Csipo I; Nakken B; Zeher M; Szegedi G; Bodolay E
Lupus; 2012 Nov; 21(13):1412-22. PubMed ID: 22864236
[TBL] [Abstract][Full Text] [Related]
56. Sjogren's syndrome is associated with and not secondary to systemic sclerosis.
Salliot C; Mouthon L; Ardizzone M; Sibilia J; Guillevin L; Gottenberg JE; Mariette X
Rheumatology (Oxford); 2007 Feb; 46(2):321-6. PubMed ID: 16877466
[TBL] [Abstract][Full Text] [Related]
57. Anti-U1 RNP antibodies in cerebrospinal fluid are associated with central neuropsychiatric manifestations in systemic lupus erythematosus and mixed connective tissue disease.
Sato T; Fujii T; Yokoyama T; Fujita Y; Imura Y; Yukawa N; Kawabata D; Nojima T; Ohmura K; Usui T; Mimori T
Arthritis Rheum; 2010 Dec; 62(12):3730-40. PubMed ID: 20722023
[TBL] [Abstract][Full Text] [Related]
58. [Sharp's syndrome. Clinical, immunological and nosographic aspects].
Scagliusi P; Muratore M; Martiradonna A; Berlingerio G; Carrozzo M
Minerva Med; 1980 Dec; 71(50):3655-63. PubMed ID: 6161325
[TBL] [Abstract][Full Text] [Related]
59. Anti-U1RNP antibodies in patients with localized scieroderma.
Yamane K; Ihn H; Kubo M; Kuwana M; Asano Y; Yazawa N; Tamaki K
Arch Dermatol Res; 2001 Sep; 293(9):455-9. PubMed ID: 11758788
[TBL] [Abstract][Full Text] [Related]
60. [Autoantibodies in systemic sclerosis: clinical interest and diagnosis approach].
Admou B; Essaadouni L; Amal S; Arji N; Chabaa L; El Aouad R
Ann Biol Clin (Paris); 2009; 67(3):273-81. PubMed ID: 19411229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]